Your browser doesn't support javascript.
loading
Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies.
Dunn, Nicky; Juto, Alexander; Ryner, Malin; Manouchehrinia, Ali; Piccoli, Luca; Fink, Katharina; Piehl, Fredrik; Fogdell-Hahn, Anna.
Afiliação
  • Dunn N; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden / Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Juto A; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden / Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Ryner M; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden / Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Manouchehrinia A; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden / Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Piccoli L; Immune Regulation Laboratory, Institute for Research in Biomedicine, Bellinzona, Switzerland.
  • Fink K; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden / Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Piehl F; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden / Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Fogdell-Hahn A; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden / Center for Molecular Medicine, Karolinska University Hospital Solna, Stockholm, Sweden.
Mult Scler ; 24(9): 1224-1233, 2018 08.
Article em En | MEDLINE | ID: mdl-28762877
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-Idiotípicos / Rituximab / Fatores Imunológicos / Esclerose Múltipla Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-Idiotípicos / Rituximab / Fatores Imunológicos / Esclerose Múltipla Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article